![Lysosomal Acid Lipase Deficiency / Wolman disease / Cholesteryl ester storage disease / Mucopolysaccharidosis / Hunter syndrome / Health / Rare diseases / Lipid storage disorders Lysosomal Acid Lipase Deficiency / Wolman disease / Cholesteryl ester storage disease / Mucopolysaccharidosis / Hunter syndrome / Health / Rare diseases / Lipid storage disorders](https://www.pdfsearch.io/img/d698e0c72d74913d3ae56ccdcbcae110.jpg)
| Document Date: 2014-08-04 12:07:09 Open Document File Size: 335,66 KBShare Result on Facebook
City RESULTS LEXINGTON / / Company Hoffman-La Roche Inc. / Synageva BioPharma Corp. / / Currency USD / / Event FDA Phase / Earnings Announcement / Earnings Guidance / / IndustryTerm biopharmaceutical company developing therapeutic products / developed technology / manufacturing capabilities / / MedicalCondition mucopolysaccharidosis IIIB / broad LAL Deficiency / accelerated atherosclerosis / LAL Deficiency LAL Deficiency / rare diseases / disease / rare autosomal recessive lysosomal storage disease / lysosomal acid lipase deficiency / cirrhosis / Cholesteryl Ester Storage Disease / Wolman disease / rare disorders / diseases / Other Pipeline Programs The mucopolysaccharidoses / deficiency / advanced liver disease / LAL Deficiency / B syndrome / / MedicalTreatment enzyme replacement therapy / / Organization European Medicines Agency / Ministry of Health / U.S. Food & Drug Administration / / Person MPS IIIB / / Position animal model / / Product Fuzeon / SBC-103 / / ProvinceOrState Massachusetts / / Technology alpha / transplantation / / URL www.synageva.com / /
SocialTag |